Reports for TEVA-BUPRENORPHINE/NALOXONE

Brand name

TEVA-BUPRENORPHINE/NALOXONE

Company Name
TEVA CANADA LIMITED
Drug Identification Number
02453908
Ingredients
BUPRENORPHINE
NALOXONE
Ingredient Strength
2 MG
0.5 MG
ATC Code
N07BC
N07BC
ATC Descriptor
DRUGS USED IN ADDICTIVE DISORDERS
DRUGS USED IN ADDICTIVE DISORDERS
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2019-10-03 2020-01-24 95396
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 30 Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 30 Actual shortage 2024-03-07 2024-03-28 221534
TEVA-BUPRENORPHINE/NALOXONE 30 bot Resolved 2021-06-03 2021-06-10 140363

Showing 1 to 6 of 6

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports

Showing 1 to 0 of 0